FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

STEFANO VELLA

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1
HIV

Procedures

Concepts & Ideas

Viral Load

Physiology

Geographic Areas

Europe

Co-author Network

Publications

TOP 3
Maria F Pirillo; Lucia Palmisano; Manuela Pellegrini; Clementina M Galluzzo; Liliana E Weimer; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Emilia Marchei; Simona Pichini; STEFANO VELLA; Marina Giuliano
Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.
Lucia Palmisano; Marina Giuliano; Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Liliana E Weimer; Maria F Pirillo; Vincenzo Fragola; Raffaella Bucciardini; STEFANO VELLA
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
Mauro Andreotti; Clementina M Galluzzo; Giovanni Guidotti; Paola Germano; Annamaria Doro Altan; Maria F Pirillo; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of STEFANO VELLA (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Maria F Pirillo; Lucia Palmisano; Manuela Pellegrini; Clementina M Galluzzo; Liliana E Weimer; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Emilia Marchei; Simona Pichini; STEFANO VELLA; Marina Giuliano
Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.
AIDS research and human retroviruses 2010;26(5):541-5.
2009: Lucia Palmisano; Marina Giuliano; Clementina M Galluzzo; Roberta Amici; Mauro Andreotti; Liliana E Weimer; Maria F Pirillo; Vincenzo Fragola; Raffaella Bucciardini; STEFANO VELLA
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
HIV medicine 2009;10(8):477-81.
2009: Mauro Andreotti; Clementina M Galluzzo; Giovanni Guidotti; Paola Germano; Annamaria Doro Altan; Maria F Pirillo; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique.
AIDS research and human retroviruses 2009;25(7):707-11.
2009: Lucia Palmisano; Marina Giuliano; Raffaella Bucciardini; Mauro Andreotti; Vincenzo Fragola; Maria F Pirillo; Liliana E Weimer; Maria G Mancini; STEFANO VELLA
Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptions.
Journal of medical microbiology 2009;58(Pt 1):121-4.
2008: Marco Floridia; Marina Giuliano; Lucia Palmisano; STEFANO VELLA
Gender differences in the treatment of HIV infection.
Pharmacological research : the official journal of the Italian Pharmacological Society 2008;58(3-4):173-82.
2008: Silvia Baroncelli; Elisabetta Ricci; Mauro Andreotti; Giovanni Guidotti; Paola Germano; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Anita De Rossi; Marina Giuliano
Single-nucleotide polymorphisms in human beta-defensin-1 gene in Mozambican HIV-1-infected women and correlation with virologic parameters.
AIDS (London, England) 2008;22(12):1515-7.
2008: Lucia Palmisano; Marina Giuliano; Flavia Chiarotti; Marisa Zanchetta; Mauro Andreotti; Maria F Pirillo; Elisabetta Riva; Guido Antonelli; Anita De Rossi; STEFANO VELLA
Modifications of HIV-1 DNA and provirus-infected cells during 24 months of intermittent highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2008;48(1):68-71.
2008: Silvia Baroncelli; Mauro Andreotti; Giovanni Guidotti; Maria F Pirillo; Susanna Ceffa; Maria Grazia Mancini; Paola Germano; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Tumor necrosis factor-alpha, Interleukin-10, and alpha-defensins in plasma and breast milk of HIV-infected highly active antiretroviral therapy-treated and untreated pregnant women in Mozambique.
Journal of acquired immune deficiency syndromes (1999) 2008;47(5):647-9.
2007: Maria F Pirillo; Luciana Bassani; Elena A P Germinario; Maria Grazia Mancini; Joseph Vyankandondera; Pius Okong; STEFANO VELLA; Marina Giuliano
Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
Journal of medical virology 2007;79(12):1797-801.
2007: Mauro Andreotti; Giovanni Guidotti; Clementina M Galluzzo; Sandro Mancinelli; Paola Germano; Maria F Pirillo; Maria Cristina Marazzi; STEFANO VELLA; leonardo Palombi; Marina Giuliano
Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention.
AIDS (London, England) 2007;21(17):2360-2.
2007: Clementina M Galluzzo; Elena A P Germinario; Luciana Bassani; Maria Grazia Mancini; Pius Okong; Joseph Vyankandondera; STEFANO VELLA; Marina Giuliano
Antiretroviral resistance mutations in untreated pregnant women with HIV infection in Uganda and Rwanda.
AIDS research and human retroviruses 2007;23(11):1449-51.
2007: Walter Malorni; Ilaria Campesi; Elisabetta Straface; STEFANO VELLA; Flavia Franconi
Redox features of the cell: a gender perspective.
Antioxidants & redox signaling 2007;9(11):1779-801.
2007: Emanuele Nicastri; Sebastiano Leone; Claudio Angeletti; Lucia Palmisano; Loredana Sarmati; Antonio Chiesi; Andrea Geraci; STEFANO VELLA; Pasquale Narciso; Angela Corpolongo; Massimo Andreoni
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review.
The Journal of antimicrobial chemotherapy 2007;60(4):724-32.
2007: Lucia Palmisano; Marina Giuliano; Raffaella Bucciardini; Vincenzo Fragola; Mauro Andreotti; Clementina M Galluzzo; Maria F Pirillo; Liliana E Weimer; Romano Arcieri; Elena A P Germinario; Roberta Amici; Maria Grazia Mancini; Antonella d'Arminio Monforte; Francesco Castelli; Pietro Caramello; STEFANO VELLA
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):39-47.
2007: Gabriella d'Ettorre; Lorenzo Zaffiri; Giancarlo Ceccarelli; Mauro Andreotti; Anna P Massetti; STEFANO VELLA; Claudio M Mastroianni; Vincenzo Vullo
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up.
HIV clinical trials 2007;8(3):182-8.
2007: C Holkmann Olsen; A Mocroft; Ole Kirk; STEFANO VELLA; Anders Blaxhult; Nathan Clumeck; M Fisher; C Katlama; A N Phillips; J D Lundgren
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
HIV medicine 2007;8(2):96-104.
2007: Marina Giuliano; Giovanni Guidotti; Mauro Andreotti; Maria F Pirillo; Paola Villani; Giuseppe Liotta; Maria Cristina Marazzi; Maria Grazia Mancini; Maria Cusato; Paola Germano; Sandra Loureiro; Susanna Ceffa; Mario Regazzi; STEFANO VELLA; leonardo Palombi
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
Journal of acquired immune deficiency syndromes (1999) 2007;44(3):286-91.
2007: Emanuela Balestrieri; Sandro Grelli; Claudia Matteucci; Antonella Minutolo; Gabriella d'Ettorre; Fiorella Di Sora; Francesco Montella; Vincenzo Vullo; STEFANO VELLA; Cartesio Favalli; Beatrice Macchi; Antonio Mastino
Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy.
Journal of medical virology 2007;79(2):111-7.
2007: Marina Giuliano; STEFANO VELLA
Inequalities in health: access to treatment for HIV/AIDS.
Annali dell'Istituto superiore di sanità 2007;43(4):313-6.
2006: Sandro Grelli; Emanuela Balestrieri; Claudia Matteucci; Antonella Minutolo; Gabriella d'Ettorre; Filippo Lauria; Francesco Montella; Vincenzo Vullo; STEFANO VELLA; Cartesio Favalli; Antonio Mastino; Beatrice Macchi
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy.
Annals of the New York Academy of Sciences 2006;1090():130-7.
2006: Roberta Bona; Mauro Andreotti; Viviana Buffa; Pasqualina Leone; Clementina M Galluzzo; Roberta Amici; Lucia Palmisano; Maria Grazia Mancini; Zuleika Michelini; Roberto Di Santo; Roberta Costi; Alessandra Roux; Yves Pommier; Christophe Marchand; STEFANO VELLA; Andrea Cara
Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds.
Antimicrobial agents and chemotherapy 2006;50(10):3407-17.
2006: Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; José M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 2006;296(7):827-43.
2006: Scott M Hammer; Michael S Saag; Mauro Schechter; Julio S G Montaner; Robert T Schooley; Donna M Jacobsen; Melanie A Thompson; Charles C J Carpenter; Margaret A Fischl; Brian G Gazzard; José M Gatell; Martin S Hirsch; David A Katzenstein; Douglas D Richman; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2006;14(3):827-43.
2006: Marina Giuliano; Clementina M Galluzzo; Elena A P Germinario; Roberta Amici; Luciana Bassani; Lorenzo Dehò; Joseph Vyankandondera; Francis Mmiro; Pius Okong; STEFANO VELLA
Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):131-3.
2006: Raffaella Bucciardini; Rita Murri; M Guarinieri; Fabrizio Starace; M Martini; A Vatrella; Loredana Cafaro; Massimo Fantoni; R Grisetti; Antonella d'Arminio Monforte; Vincenzo Fragola; Romano Arcieri; Cosmo Del Borgo; Andrea Tramarin; Maurizio Massella; D Lorenzetti; STEFANO VELLA
ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2006;15(3):377-90.
2006: Gabriella d'Ettorre; Mauro Andreotti; Martina Carnevalini; Carolina Andreoni; Lorenzo Zaffiri; Vincenzo Vullo; STEFANO VELLA; Claudio M Mastroianni
Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patients.
Immunology letters 2006;103(2):192-5.
2006: Pietro Panei; Anne-Laure Knellwolf; Romano Arcieri; STEFANO VELLA
Absence of unfavorable effect of atomoxetine on growth in pediatric patients is still not demonstrated.
Pediatrics 2006;117(2):587-8; author reply 588.
2006: Wendy P Bannister; Lidia Ruiz; Clive Loveday; STEFANO VELLA; Kai Zilmer; Jesper Kjaer; Brygida Knysz; Andrew N Phillips; Amanda Mocroft
HIV-1 subtypes and response to combination antiretroviral therapy in Europe.
Antiviral therapy 2006;11(6):707-15.
2005: Loredana Sarmati; Saverio G Parisi; Emanuele Nicastri; Gabriella d'Ettorre; Lucia Palmisano; Mauro Andreotti; Carolina Andreoni; Marina Giuliano; Francesca Gatti; Caterina Boldrin; Giorgio Palù; Vincenzo Vullo; STEFANO VELLA; Massimo Andreoni
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy.
Journal of clinical microbiology 2005;43(12):6183-5.
2005: Lucia Palmisano; Marina Giuliano; Emanuele Nicastri; Maria F Pirillo; Mauro Andreotti; Clementina M Galluzzo; Raffaella Bucciardini; Vincenzo Fragola; Massimo Andreoni; STEFANO VELLA
Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.
AIDS (London, England) 2005;19(16):1843-7.
2005: STEFANO VELLA; Lucia Palmisano
The global status of resistance to antiretroviral drugs.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41 Suppl 4():S239-46.
2005: Emanuele Nicastri; Antonio Chiesi; Claudio Angeletti; Loredana Sarmati; Lucia Palmisano; Andrea Geraci; Massimo Andreoni; STEFANO VELLA
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART.
Journal of medical virology 2005;76(2):153-60.
2005: Deborah Konopnicki; Amanda Mocroft; Stéphane De Wit; Francisco Antunes; bruno ledergerber; Christine Katlama; K Zilmer; STEFANO VELLA; Ole Kirk; Jens D Lundgren
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.
AIDS (London, England) 2005;19(6):593-601.
2005: Emanuele Nicastri; Claudio Angeletti; Lucia Palmisano; Loredana Sarmati; Antonio Chiesi; Andrea Geraci; Massimo Andreoni; STEFANO VELLA
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy.
AIDS (London, England) 2005;19(6):577-83.
2005: Michele Magoni; Luciana Bassani; Pius Okong; Praxedes Kituuka; Elena Germinario; Marina Giuliano; STEFANO VELLA
Mode of infant feeding and HIV infection in children in a program for prevention of mother-to-child transmission in Uganda.
AIDS (London, England) 2005;19(4):433-7.
2004: Anne-Mieke Vandamme; Anders Sönnerborg; M Ait-Khaled; J Albert; B Asjo; Lee Bacheler; D Banhegyi; C Boucher; F Brun-Vézinet; R Camacho; P Clevenbergh; N Clumeck; N Dedes; Andrea De Luca; H W Doerr; J L Faudon; G Gatti; J Gerstoft; W W Hall; A Hatzakis; N Hellmann; A Horban; J D Lundgren; D Kempf; M Miller; V Miller; T W Myers; C Nielsen; M Opravil; L Palmisano; C F Perno; A Phillips; D Pillay; T Pumarola; L Ruiz; M Salminen; J Schapiro; B Schmidt; Jean-Claude Schmit; R Schuurman; E Shulse; V Soriano; S Staszewski; STEFANO VELLA; M Youle; R Ziermann; L Perrin
Updated European recommendations for the clinical use of HIV drug resistance testing.
Antiviral therapy 2004;9(6):829-48.
2004: Amanda Mocroft; José M Gatell; Peter Reiss; bruno ledergerber; Ole Kirk; STEFANO VELLA; Anders Blaxhult; Andrew N Phillips; Jens Lundgren
Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.
AIDS (London, England) 2004;18(17):2333-7.
2004: STEFANO VELLA
HIV clinical research in developing countries: challenges and priorities.
Journal of HIV therapy 2004;9(3):49.
2004: Emanuele Nicastri; Loredana Sarmati; Gabriella d'Ettorre; Saverio G Parisi; Lucia Palmisano; Marco Montano; Anna Rita Buonomini; Clementina M Galluzzo; Vincenzo Vullo; Ercole Concia; STEFANO VELLA; Massimo Andreoni
Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy.
AIDS research and human retroviruses 2004;20(8):816-8.
2004: Pietro Panei; Romano Arcieri; STEFANO VELLA; Maurizio Bonati; Nello Martini; Alessandro Zuddas
Italian attention-deficit/hyperactivity disorder registry.
Pediatrics 2004;114(2):514.
2004: Patrick G Yeni; Scott M Hammer; Martin S Hirsch; Michael S Saag; Mauro Schechter; Charles C J Carpenter; Margaret A Fischl; José M Gatell; Brian G Gazzard; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Paul A Volberding
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2004;292(2):251-65.
2004: Ulrik B Dragsted; Amanda Mocroft; STEFANO VELLA; Jean-Paul Viard; Ann-Brit Eg Hansen; George Panos; Danielle Mercey; Ladislav Machala; Andrzej Horban; Jens D Lundgren
Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study.
The Journal of infectious diseases 2004;190(1):148-55.
2004: Nancy R Reynolds; Marcia A Testa; Linda G Marc; Margaret A Chesney; Judith L Neidig; Scott R Smith; STEFANO VELLA; Gregory Robbins
Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.
AIDS and behavior 2004;8(2):141-50.
2004: Antonella d'Arminio Monforte; Paola Cinque; Amanda Mocroft; Frank-Detlev Goebel; Francisco Antunes; Christine Katlama; Ulrik S Justesen; STEFANO VELLA; Ole Kirk; Jens Lundgren
Changing incidence of central nervous system diseases in the EuroSIDA cohort.
Annals of neurology 2004;55(3):320-8.
2004: Sandro Grelli; Gabriella d'Ettorre; Filippo Lauria; Francesco Montella; Loide Di Traglia; Miriam Lichtner; Vincenzo Vullo; Cartesio Favalli; STEFANO VELLA; Beatrice Macchi; Antonio Mastino
Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients.
The Journal of antimicrobial chemotherapy 2004;53(3):494-500.
2004: Gabriella d'Ettorre; Gabriele Forcina; Mauro Andreotti; Loredana Sarmati; Lucia Palmisano; Massimo Andreoni; STEFANO VELLA; Claudio M Mastroianni; Vincenzo Vullo
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
Clinical and experimental immunology 2004;135(2):280-5.
2004: Marco Floridia; Raffaella Bucciardini; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Roberta Amici; Mauro Andreotti; D Ricciardulli; C Tomino; STEFANO VELLA
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL).
HIV medicine 2004;5(1):1-10.
2003: Robert W Shafer; Laura M Smeaton; Gregory Robbins; Victor De Gruttola; Snyder Sally; Richard T D'Aquila; Victoria A Johnson; Gene D Morse; Mostafa Nokta; Ana I Martinez; Barbara Gripshover; Pamposh Kaul; Richard Haubrich; Mary Swingle; S Debra McCarty; STEFANO VELLA; Martin S Hirsch; Thomas C Merigan
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
The New England journal of medicine 2003;349(24):2304-15.
2003: Gregory Robbins; Victor De Gruttola; Robert W Shafer; Laura M Smeaton; Snyder Sally; Carla Pettinelli; Michael P Dubé; Margaret A Fischl; Richard B Pollard; Robert Delapenha; Linda Gedeon; Charles van der Horst; Robert L Murphy; Mark I Becker; Richard T D'Aquila; STEFANO VELLA; Thomas C Merigan; Martin S Hirsch
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.
The New England journal of medicine 2003;349(24):2293-303.
2003: Sandro Grelli; Gabriella D'Ettore; Filippo Lauria; Francesco Montella; Loide Di Traglia; Cartesio D'Agostini; Miriam Lichtner; Vincenzo Vullo; Cartesio Favalli; STEFANO VELLA; Beatrice Macchi; Antonio Mastino
CD4+ lymphocyte increases in HIV patients during potent antiretroviral therapy are dependent on inhibition of CD8+ cell apoptosis.
Annals of the New York Academy of Sciences 2003;1010():560-4.
2003: STEFANO VELLA
Future treatment perspectives.
Journal of acquired immune deficiency syndromes (1999) 2003;34 Suppl 1():S95-100.
2003: Margaret A Fischl; Heather J Ribaudo; Ann C Collier; Alejo Erice; Marina Giuliano; Marjorie Dehlinger; Joseph J Eron; Michael S Saag; Scott M Hammer; STEFANO VELLA; Gene D Morse; Judith E Feinberg; Lisa M Demeter; Susan H Eshleman
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease.
The Journal of infectious diseases 2003;188(5):625-34.
2003: Simonetta Di Fabio; Jens Van Roey; Giacomo Giannini; Guy Van den Mooter; Massimo Spada; Andrea Binelli; Maria F Pirillo; Elena Germinario; Filippo Belardelli; Marie-Pierre de Bethune; STEFANO VELLA
Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation.
AIDS (London, England) 2003;17(11):1597-604.
2003: Marina Giuliano; Lucia Palmisano; Clementina M Galluzzo; Roberta Amici; Elena Germinario; Pius Okong; Praxedes Kituuka; Francis Mmirro; Michele Magoni; STEFANO VELLA
Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission.
AIDS (London, England) 2003;17(10):1570-2.
2003: Eric Florence; Jens Lundgren; C Dreezen; M Fisher; Ole Kirk; Anders Blaxhult; George Panos; Christine Katlama; STEFANO VELLA; A Phillips
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.
HIV medicine 2003;4(3):255-62.
2003: Emanuele Nicastri; Loredana Sarmati; Gabriella d'Ettorre; Saverio G Parisi; Lucia Palmisano; Clementina M Galluzzo; Marco Montano; Ilaria Uccella; Roberta Amici; Francesca Gatti; Vincenzo Vullo; Ercole Concia; STEFANO VELLA; Massimo Andreoni
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis.
Journal of clinical microbiology 2003;41(7):3007-12.
2003: Paola Matarrese; Lucrezia Gambardella; Antonio Cassone; STEFANO VELLA; Roberto Cauda; Walter Malorni
Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(12):6006-15.
2003: STEFANO VELLA; Lucia Palmisano
Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?
Journal of HIV therapy 2003;8(2):27-8.
2003: Alessandro Cozzi-Lepri; Andrew N Phillips; Veronica Miller; Christine Katlama; bruno ledergerber; STEFANO VELLA; Jonathan Weber; Johan Bruun; Ole Kirk; Bonaventura Clotet; Jens D Lundgrens
Changes in viral load in people with virological failure who remain on the same HAART regimen.
Antiviral therapy 2003;8(2):127-36.
2003: Loredana Sarmati; Emanuele Nicastri; Ilaria Uccella; Gabriella d'Ettorre; Saverio G Parisi; Lucia Palmisano; Clementina M Galluzzo; Ercole Concia; Vincenzo Vullo; STEFANO VELLA; Massimo Andreoni
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing.
Journal of clinical microbiology 2003;41(4):1760-2.
2003: Emanuele Nicastri; Loredana Sarmati; Gabriella d'Ettorre; Lucia Palmisano; Saverio G Parisi; Ilaria Uccella; Alessia Rianda; Ercole Concia; Vincenzo Vullo; STEFANO VELLA; Massimo Andreoni
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Journal of medical virology 2003;69(1):1-6.
2002: Hogg Robert; Pedro Cahn; Elly Katabira; Joep Lange; N M Samuel; Michael O'Shaughnessy; STEFANO VELLA; Mark A Wainberg; Julio Montaner
Time to act: global apathy towards HIV/AIDS is a crime against humanity.
Lancet 2002;360(9347):1710-1.
2002: Maria Cristina Marazzi; leonardo Palombi; Leonardo Emberti Gialloreti; Giovanni Guidotti; Giuseppe Liotta; Federico Perno; STEFANO VELLA; Pasquale Narciso
[DREAM project early results (drug resources enhancement against AIDS in Mozambique)].
Igiene e sanità pubblica 2002;58(6):431-40.
2002: Gabriella d'Ettorre; Gabriele Forcina; Mauro Andreotti; Loredana Sarmati; Lucia Palmisano; Clementina M Galluzzo; Emanuele Nicastri; Claudio M Mastroianni; Vincenzo Vullo; STEFANO VELLA; Massimo Andreoni
Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production.
AIDS (London, England) 2002;16(14):1877-85.
2002: STEFANO VELLA
Antiretroviral drug resistance and HIV/AIDS in the developing world.
Journal of HIV therapy 2002;7(3):53-5.
2002: Mothanje Barbara Lucia; Sergio Rutella; Giuseppe Leone; Luigi Maria Larocca; STEFANO VELLA; Roberto Cauda
In vitro and in vivo modulation of MDR1/P-glycoprotein in HIV-infected patients administered highly active antiretroviral therapy and liposomal doxorubicin.
Journal of acquired immune deficiency syndromes (1999) 2002;30(4):369-78.
2002: Veronica Miller; Andrew N Phillips; Bonaventura Clotet; Amanda Mocroft; bruno ledergerber; Ole Kirk; Vidar Ormaasen; Panagiotis Gargalianos-Kakolyris; STEFANO VELLA; Jens D Lundgren
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts.
The Journal of infectious diseases 2002;186(2):189-97.
2002: Patrick G Yeni; Scott M Hammer; Charles C J Carpenter; David A Cooper; Margaret A Fischl; José M Gatell; Brian G Gazzard; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Paul A Volberding
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2002;288(2):222-35.
2002: Diane V Havlir; STEFANO VELLA; Scott Hammer
The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society.
AIDS (London, England) 2002;16(10):7-9.
2002: Marco Floridia; Vincenzo Fragola; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; C Tomino; STEFANO VELLA
HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/microL): an analysis of 338 clinical events from a randomized clinical trial.
HIV medicine 2002;3(2):75-84.
2002: STEFANO VELLA
Access to HIV care and treatment in the developing world: responding to the objections.
AIDS clinical care 2002;14(3):19-21, 23, 26.
2001: Simonetta Di Fabio; Giacomo Giannini; Caterina Lapenta; Massimo Spada; Andrea Binelli; Elena Germinario; Paola Sestili; Filippo Belardelli; Enrico Proietti; STEFANO VELLA
Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.
AIDS (London, England) 2001;15(17):2231-8.
2001: Alessandra Viganò; Marcello Pinti; Milena Nasi; L Moretti; Fiorella Balli; Cristina Mussini; Dorella Bricalli; N Sala; Roberto Bugarini; STEFANO VELLA; Nicola Principi; Andrea Cossarizza
Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: the role of age.
The Journal of allergy and clinical immunology 2001;108(3):439-45.
2001: STEFANO VELLA; L Palmisano
Facing an emerging threat: the spread of HIV resistance.
Journal of HIV therapy 2001;6(3):49-50.
2001: M B Lucia; Sergio Rutella; G Leone; STEFANO VELLA; R Cauda
HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Journal of acquired immune deficiency syndromes (1999) 2001;27(4):321-30.
2001: P Hale; M W Makgoba; Michael H Merson; Thomas C Quinn; D D Richman; STEFANO VELLA; F Wabwire-Mangen; S Wain-Hobson; R A Weiss
Success hinges on support for treatment.
Nature 2001;412(6844):272.
2001: P Hale; M W Makgoba; Michael H Merson; Thomas C Quinn; D D Richman; STEFANO VELLA; F Wabwire-Mangen; S Wain-Hobson; R A Weiss
Mission now possible for AIDS fund.
Nature 2001;412(6844):271-2.
2001: Brian Conway; Mark A Wainberg; D Hall; Marianne Harris; P Reiss; D Cooper; STEFANO VELLA; R Curry; P Robinson; J M Lange; Julio S G Montaner
Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.
AIDS (London, England) 2001;15(10):1269-74.
2001: Sandro Grelli; Loide Di Traglia; Claudia Matteucci; Miriam Lichtner; Vincenzo Vullo; Fiorella Di Sora; Filippo Lauria; Francesco Montella; Cartesio Favalli; STEFANO VELLA; Beatrice Macchi; Antonio Mastino
Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression.
AIDS (London, England) 2001;15(9):1178-81.
2001: Agnes I Veldkamp; Gerrit Jan Weverling; Joep M A Lange; J S Montaner; Peter Reiss; D A Cooper; STEFANO VELLA; D Hall; Jos H Beijnen; Richard Hoetelmans
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.
AIDS (London, England) 2001;15(9):1089-95.
2001: L O Kallings; STEFANO VELLA
Access to HIV/AIDS care and treatment in the south of the world.
AIDS (London, England) 2001;15(7):IAS1-3.
2001: Paola Matarrese; Ugo Testa; Roberto Cauda; STEFANO VELLA; Lucrezia Gambardella; Walter Malorni
Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis.
The Biochemical journal 2001;355(Pt 3):587-95.
2000: Marco Floridia; C Tomino; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Roberta Amici; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; AC Seeber; Adriana Ammassari; A Cingolani; Adriano Lazzarin; G Scalise; Antonietta Cargnel; Fredy Suter; F Milazzo; G Pastore; Mauro Moroni; R Ciammarughi; R Pini; Giampiero Carosi; C D'Amato; L Contu; Ercole Concia; L Bonazzi; Fernando Aiuti; Gianmarco Vigevani; STEFANO VELLA
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.
AIDS research and human retroviruses 2000;16(17):1809-20.
2000: Raffaella Bucciardini; Albert W Wu; Marco Floridia; Vincenzo Fragola; D Ricciardulli; C Tomino; Liliana E Weimer; Maria F Pirillo; Marco Mirra; MAURO MARZI; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Maurizio Massella; STEFANO VELLA
Quality of life outcomes of combination zidovudine- didanosine-nevirapine and zidovudine-didanosine for antiretroviral-naive advanced HIV-infected patients.
AIDS (London, England) 2000;14(16):2567-74.
2000: Marco Floridia; Maurizio Massella; Raffaella Bucciardini; C A Perucci; L Rossi; C Tomino; Vincenzo Fragola; D Ricciardulli; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; Marco Mirra; STEFANO VELLA
Hospitalizations and costs of treatment for protease inhibitor-based regimens in patients with very advanced HIV-infection (CD4 < 50/mm(3)).
HIV clinical trials 2000;1(2):9-16.
2000: Giuseppe BENAGIANO; G Rezza; STEFANO VELLA
Condom use for preventing the spread of HIV/AIDS: an ethical imperative.
Journal of the Royal Society of Medicine 2000;93(9):453-6.
2000: STEFANO VELLA; Mariangela Galluzzo; Giacomo Giannini; Maria F Pirillo; Mauro Andreotti; C Tomino; Vincenzo Fragola; Raffaella Bucciardini; D Ricciardulli; Andrea Binelli; Liliana E Weimer; Marco Floridia
Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment.
Antiviral research 2000;47(3):189-98.
2000: Kristien Van Vaerenbergh; Kristel Van Laethem; J Albert; C A Boucher; Bonaventura Clotet; Marco Floridia; J Gerstoft; B Hejdeman; C Nielsen; Christophe Pannecouque; L Perrin; Maria F Pirillo; Lidia Ruiz; Jean-Claude Schmit; F Schneider; A Schoolmeester; R Schuurman; Hans-Jürgen Stellbrink; Lieven Stuyver; Jan van Lunzen; Barbara Van Remoortel; Eric Van Wijngaerden; STEFANO VELLA; Myriam Witvrouw; S Yerly; Erik De Clercq; J Destmyer; Anne-Mieke Vandamme
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.
Antimicrobial agents and chemotherapy 2000;44(8):2109-17.
2000: STEFANO VELLA
Structured treatment interruptions and treatment intensification.
AIDS clinical care 2000;12(7):55-7, 62.
2000: Sandro Grelli; S Campagna; Miriam Lichtner; G Ricci; STEFANO VELLA; Vincenzo Vullo; Francesco Montella; S Di Fabio; Cartesio Favalli; Antonio Mastino; Beatrice Macchi
Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy.
AIDS (London, England) 2000;14(8):939-49.
2000: Martin S Hirsch; Françoise Brun-Vézinet; Richard T D'Aquila; Scott M Hammer; Victoria A Johnson; Daniel R Kuritzkes; Clive Loveday; John W Mellors; Bonaventura Clotet; Brian Conway; Lisa M Demeter; STEFANO VELLA; Donna M Jacobsen; Douglas D Richman
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2000;283(18):2417-26.
2000: Andrea Cossarizza; G Stent; Cristina Mussini; Roberto Paganelli; Vanni Borghi; C Nuzzo; Marcello Pinti; J Pedrazzi; F Benatti; Roberto Esposito; Bård Ingvald Røsok; S Nagata; STEFANO VELLA; Claudio Franceschi; B De Rienzo
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
AIDS (London, England) 2000;14(4):345-55.
2000: Giorgio Gatti; A Vigano'; N Sala; STEFANO VELLA; Matteo Bassetti; Dante Bassetti; Nicola Principi
Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection.
Antimicrobial agents and chemotherapy 2000;44(3):752-5.
2000: Alessandra Vigano; STEFANO VELLA; Marina Saresella; Angelo Vanzulli; Dorella Bricalli; S Di Fabio; Pasquale Ferrante; M Andreotti; Maria F Pirillo; LG Dally; Mario Clerici; Nicola Principi
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
AIDS (London, England) 2000;14(3):251-61.
2000: STEFANO VELLA; L Palmisano
HIV eradication revisited.
Expert opinion on investigational drugs 2000;9(2):193-7.
2000: Charles C J Carpenter; D A Cooper; Margaret A Fischl; José M Gatell; Brian G Gazzard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Mauro Schechter; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 2000;283(3):381-90.
2000: STEFANO VELLA; Lucia Palmisano
Antiretroviral therapy: state of the HAART.
Antiviral research 2000;45(1):1-7.
2000: STEFANO VELLA; Lucia Palmisano
HIV therapy in the post-eradication era.
Journal of biological regulators and homeostatic agents 2000;14(1):34-7.
1999: Alessandra Viganò; LG Dally; Dorella Bricalli; N Sala; Maria F Pirillo; Marina Saresella; Daria Trabattoni; STEFANO VELLA; Mario Clerici; Nicola Principi
Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection.
The Journal of pediatrics 1999;135(6):675-82.
1999: Janet Raboud; Sandra Rae; STEFANO VELLA; P Richard Harrigan; Raffaella Bucciardini; Vincenzo Fragola; D Ricciardulli; Julio S G Montaner
Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV. INCAS study team.
Journal of acquired immune deficiency syndromes (1999) 1999;22(3):260-6.
1999: Giorgio Gatti; Antonio Di Biagio; R Casazza; Cleta Raffaella De Pascalis; Matteo Bassetti; Mario Cruciani; STEFANO VELLA; Dante Bassetti
The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring.
AIDS (London, England) 1999;13(15):2083-9.
1999: CM Lyles; Maria Dorrucci; David Vlahov; Patrizio Pezzotti; Gioacchino Angarano; Alessandro Sinicco; Francesco Alberici; T M Alcorn; STEFANO VELLA; Giovanni Rezza
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load.
The Journal of infectious diseases 1999;180(4):1018-24.
1999: Donald E Craven; STEFANO VELLA
A case for proactive switching?
AIDS clinical care 1999;11(8):66-7.
1999: Francesco Dragoni; Arturo Cafolla; Giuseppe Gentile; Maria Gabriella Mazzucconi; STEFANO VELLA; U Di Corpo; Maria Elena Tosti; Giulio Pisani; Vittorio Donato; Pietro Martino
HIV-HCV RNA loads and liver failure in coinfected patients with coagulopathy.
Haematologica 1999;84(6):525-9.
1999: A Vigano'; STEFANO VELLA; Nicola Principi; Dorella Bricalli; N Sala; A Salvaggio; Marina Saresella; Angelo Vanzulli; Mario Clerici
Thymus volume correlates with the progression of vertical HIV infection.
AIDS (London, England) 1999;13(5):F29-34.
1999: Robert Yarchoan; STEFANO VELLA
AIDS 1999. Clinical treatment: overview.
AIDS (London, England) 1999;13 Suppl A():S175-6.
1999: Marco Floridia; Raffaella Bucciardini; D Ricciardulli; Vincenzo Fragola; Maria F Pirillo; Liliana E Weimer; C Tomino; Giacomo Giannini; Clementina M Galluzzo; Mauro Andreotti; Antonietta Cargnel; Francesco Alberici; B De Rienzo; Francesco Leoncini; F Fiaccadori; Daniela Francisci; W Grillone; L Ortona; M Piazza; A Scalzini; E Nigra; F Tumietto; STEFANO VELLA
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1999;20(1):11-9.
1998: Massimo Andreoni; Loredana Sarmati; Emanuele Nicastri; L Ventura; Lucia Ercoli; Saverio G Parisi; Giacomo Giannini; Clementina M Galluzzo; STEFANO VELLA
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy.
Journal of medical virology 1998;56(4):332-6.
1998: Amanda Mocroft; STEFANO VELLA; T L Benfield; Antonio Chiesi; Veronica Miller; Panagiotis Gargalianos; Antonella d'Arminio Monforte; Israel Yust; JN Bruun; Andrew N Phillips; Jens D Lundgren
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.
Lancet 1998;352(9142):1725-30.
1998: Sandra Rae; Janet Raboud; Brian Conway; P Reiss; STEFANO VELLA; D Cooper; J Lange; Marianne Harris; Mark A Wainberg; P Robinson; M Myers; D Hall; Julio S G Montaner
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependent.
AIDS (London, England) 1998;12(16):2185-92.
1998: Julio S G Montaner; Janet Raboud; Sandra Rae; STEFANO VELLA
British HIV Association guidelines.
Lancet 1998;352(9135):1226-7.
1998: Janet Raboud; Julio S G Montaner; Brian Conway; Sandra Rae; P Reiss; STEFANO VELLA; D Cooper; J Lange; Marianne Harris; Mark A Wainberg; P Robinson; M Myers; D Hall
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.
AIDS (London, England) 1998;12(13):1619-24.
1998: STEFANO VELLA
HIV treatment--a rational approach to the use of antiretroviral agents.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):616-8.
1998: Charles C J Carpenter; Margaret A Fischl; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association 1998;280(1):78-86.
1998: Martin S Hirsch; Brian Conway; Richard T D'Aquila; Victoria A Johnson; Françoise Brun-Vézinet; Bonaventura Clotet; Lisa M Demeter; Scott M Hammer; Donna M Jacobsen; Daniel R Kuritzkes; Clive Loveday; John W Mellors; STEFANO VELLA; Douglas D Richman
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.
JAMA : the journal of the American Medical Association 1998;279(24):1984-91.
1998: D B Hall; J G Montaner; P Reiss; D Cooper; STEFANO VELLA; C Dohnanyi; M Myers; J Lange; B Conway
Induction-maintenance antiretroviral therapy: proof of concept.
AIDS (London, England) 1998;12(7):F41-4.
1998: O Pontesilli; EC Guerra; Adriana Ammassari; C Tomino; Marta Carlesimo; Andrea Antinori; Enrica Tamburrini; A Prozzo; AC Seeber; STEFANO VELLA; L Ortona; Fernando Aiuti
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.
AIDS (London, England) 1998;12(5):473-80.
1998: J S Montaner; P Reiss; D Cooper; STEFANO VELLA; M Harris; B Conway; M A Wainberg; D Smith; P Robinson; D Hall; M Myers; J M Lange
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
JAMA : the journal of the American Medical Association 1998;279(12):930-7.
1998: STEFANO VELLA
Advances in the virology of HIV infections and implications for clinical management.
AIDS clinical care 1998;10(3):17-9.
1998: STEFANO VELLA; Marco Floridia
Saquinavir. Clinical pharmacology and efficacy.
Clinical pharmacokinetics 1998;34(3):189-201.
1998: Andrew N Phillips; C Katlama; S Barton; STEFANO VELLA; Anders Blaxhult; Bonaventura Clotet; F D Goebel; Bernard Hirschel; C Pedersen; J D Lundgren
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;17(3):239-44.
1998: STEFANO VELLA; Donna Mildvan
AIDS 1998. Clinical treatment: overview.
AIDS (London, England) 1998;12 Suppl A():S147-8.
1998: PA Napoli; Maria Dorrucci; Diego Serraino; Patrizio Pezzotti; S Franceschi; STEFANO VELLA; Giovanni Rezza
Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii Pneumonia (PCP) before AIDS diagnosis in Italy.
European journal of epidemiology 1998;14(1):41-7.
1998: Menno D De Jong; Charles A B Boucher; Sven A Danner; B Gazzard; P D Griffiths; C Katlama; J M Lange; DD Richman; STEFANO VELLA
Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections.
Antiviral research 1998;37(1):1-16.
1997: Loredana Sarmati; Emanuele Nicastri; Gamal El Sawaf; L Ventura; A Salanitro; Lucia Ercoli; STEFANO VELLA; Massimo Andreoni
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (Invirase) treatment.
Journal of medical virology 1997;53(4):313-8.
1997: J D Lundgren; A N Phillips; STEFANO VELLA; C Katlama; bruno ledergerber; A M Johnson; P Reiss; J Gatell; Nathan Clumeck; M Dietrich; Thomas Benfield; Jens Ole Nielsen; C Pedersen
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(3):153-60.
1997: Lucia Ercoli; Loredana Sarmati; Emanuele Nicastri; Giacomo Giannini; Clementina M Galluzzo; STEFANO VELLA; Massimo Andreoni
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.
AIDS (London, England) 1997;11(10):1211-7.
1997: Charles C J Carpenter; Margaret A Fischl; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; Julio S G Montaner; Douglas D Richman; Michael S Saag; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association 1997;277(24):1962-9.
1997: STEFANO VELLA
Clinical implications of resistance to antiretroviral drugs.
AIDS clinical care 1997;9(6):45-7, 49, 52.
1997: Massimo Andreoni; Loredana Sarmati; Lucia Ercoli; Emanuele Nicastri; Giacomo Giannini; Clementina M Galluzzo; Maria F Pirillo; STEFANO VELLA
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy.
AIDS research and human retroviruses 1997;13(7):555-61.
1997: Amanda Mocroft; J D Lundgren; A d'Armino Monforte; bruno ledergerber; S E Barton; STEFANO VELLA; C Katlama; J Gerstoft; C Pedersen; Andrew N Phillips
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.
International journal of epidemiology 1997;26(2):400-7.
1997: Menno D De Jong; STEFANO VELLA; Andrew Carr; Charles A B Boucher; A Imrie; Martyn French; Jennifer Hoy; S Sorice; S Pauluzzi; F Chiodo; Gerrit Jan Weverling; Marchina E Van Der Ende; P J Frissen; Hugo M Weigel; Robbert H Kauffmann; Joep M A Lange; R Yoon; M Moroni; E Hoenderdos; G Leitz; David A Cooper; D Hall; Peter Reiss
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.
The Journal of infectious diseases 1997;175(4):966-70.
1997: Marco Floridia; STEFANO VELLA; AC Seeber; C Tomino; Vincenzo Fragola; Liliana E Weimer; D Ricciardulli; F Milazzo; F M Gritti; Francesco Mazzotta; S Ranieri; F Chiodo; Mauro Moroni; Antonietta Cargnel; D Bassetti; V Giannini; L Cremoni; Ercole Concia; Alessandro Sinicco; Giampiero Carosi; Francesco Alberici; Ferdinando Dianzani
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.
The Journal of infectious diseases 1997;175(2):255-64.
1997: STEFANO VELLA; Vincenzo Fragola; Lucia Palmisano
Recent advances in antiretroviral therapy of HIV infection.
Journal of biological regulators and homeostatic agents 1997;11(1-2):60-3.
1996: Antonio Chiesi; AC Seeber; L G Dally; Marco Floridia; Giovanni Rezza; STEFANO VELLA
AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection.
Journal of the neurological sciences 1996;144(1-2):107-13.
1996: STEFANO VELLA; Marco Floridia; L G Dally; C Tomino; Vincenzo Fragola; Liliana E Weimer; Francesco Milazzo; Francesco Mazzotta; Mauro Moroni; G Pastore; G Scalise; Alessandro Sinicco; L Ortona; B De Rienzo; Ferdinando Dianzani
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(5):462-9.
1996: STEFANO VELLA; Adriano Lazzarin; G Carosi; Alessandro Sinicco; O Armignacco; G Angarano; Massimo Andreoni; G Tambussi; A Chiodera; Marco Floridia; S Scaccabarozzi; K Facey; I Duncan; P Boudes; K Bragman
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
Antiviral therapy 1996;1(3):129-40.
1996: P Sudre; Bernard Hirschel; J M Gatell; S Schwander; STEFANO VELLA; C Katlama; bruno ledergerber; A d'Arminio Monforte; F D Goebel; P O Pehrson; C Pedersen; J D Lundgren
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1996;77(4):322-8.
1996: Charles C J Carpenter; Margaret A Fischl; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; David A Katzenstein; J S Montaner; Douglas D Richman; M S Sáag; Robert T Schooley; Melanie A Thompson; STEFANO VELLA; Patrick G Yeni; Paul A Volberding
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.
JAMA : the journal of the American Medical Association 1996;276(2):146-54.
1996: Philippe Hermans; J Lundgren; B Sommereijns; C Pedersen; STEFANO VELLA; Christine Katlama; R Lüthy; A J Pinching; J Gerstoft; P Pehrson; Nathan Clumeck
Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
AIDS (London, England) 1996;10(8):911-7.
1996: Andrew Carr; STEFANO VELLA; Menno D De Jong; F Sorice; A Imrie; Charles A B Boucher; David A Cooper
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.
AIDS (London, England) 1996;10(6):635-41.
1996: Helmut Jacobsen; M Hänggi; M Ott; I B Duncan; S Owen; M Andreoni; STEFANO VELLA; J Mous
In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies.
The Journal of infectious diseases 1996;173(6):1379-87.
1996: L Corey; M Hirsch; G Skowron; STEFANO VELLA
The use of protease inhibitors. A sampling of opinions. Interview by Deborah J Cotton.
AIDS clinical care 1996;8(5):37-41.
1996: STEFANO VELLA; M Franca Pirillo
Combination therapy in the management of HIV infection.
Methods and findings in experimental and clinical pharmacology 1996;18 Suppl C():23-6.
1996: Helmut Jacobsen; M Haenggi; M Ott; I B Duncan; M Andreoni; STEFANO VELLA; J Mous
Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials.
Antiviral research 1996;29(1):95-7.
1996: STEFANO VELLA; Clementina M Galluzzo; Giacomo Giannini; Maria F Pirillo; I Duncan; H Jacobsen; Massimo Andreoni; Loredana Sarmati; Lucia Ercoli
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.
Antiviral research 1996;29(1):91-3.
1996: Antonio Chiesi; STEFANO VELLA; L G Dally; C Pedersen; S Danner; A M Johnson; S Schwander; F D Goebel; M Glauser; F Antunes
Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(1):39-44.
1995: STEFANO VELLA
Protease inhibitors and nucleosides: how many? when? An interview with Stefano Vella, MD. Interview by Mark Mascolini.
Journal of the International Association of Physicians in AIDS Care 1995;1(11):12-8.
1995: STEFANO VELLA
Clinical experience with saquinavir.
AIDS (London, England) 1995;9 Suppl 2():S21-S25.
1995: STEFANO VELLA
Update on HIV protease inhibitors.
AIDS clinical care 1995;7(10):79-82, 88.
1995: STEFANO VELLA
Immunological and virological markers in HIV infection.
AIDS clinical care 1995;7(5):37-40.
1995: STEFANO VELLA
Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10 Suppl 1():S58-61.
1995: STEFANO VELLA
HIV pathogenesis and treatment strategies.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;10 Suppl 1():S20-3.
1995: STEFANO VELLA; M Giuliano; Marco Floridia; Antonio Chiesi; C Tomino; AC Seeber; S Barcherini; Raffaella Bucciardini; S Mariotti
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
AIDS (London, England) 1995;9(1):51-6.
1994: STEFANO VELLA
HIV therapy advances. Update on a proteinase inhibitor.
AIDS (London, England) 1994;8 Suppl 3():S25-9.
1994: STEFANO VELLA
Update on antiretroviral therapy of HIV infection.
Journal of biological regulators and homeostatic agents 1994;8(3):71-6.
1994: J D Lundgren; C Pedersen; N Clumeck; J M Gatell; A M Johnson; bruno ledergerber; STEFANO VELLA; A Phillips; J O Nielsen
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group.
BMJ (Clinical research ed.) 1994;308(6936):1068-73.
1994: STEFANO VELLA; Antonio Chiesi; A Volpi; M Giuliano; Marco Floridia; L G Dally; N Binkin
Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions.
JAMA : the journal of the American Medical Association 1994;271(15):1197-9.
1994: J D Lundgren; A N Phillips; C Pedersen; N Clumeck; J M Gatell; A M Johnson; bruno ledergerber; STEFANO VELLA; J O Nielsen
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.
JAMA : the journal of the American Medical Association 1994;271(14):1088-92.
1994: STEFANO VELLA; Marco Floridia; Antonio Chiesi; C Tomino; D Ricciardulli
Recent advances in antiretroviral therapy of HIV infection.
Rays 1994;19(2):198-207.
1994: Loredana Sarmati; Lucia Ercoli; Saverio G Parisi; Giovanni Rocchi; Giacomo Giannini; Clementina M Galluzzo; STEFANO VELLA; Massimo Andreoni
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment.
Journal of acquired immune deficiency syndromes 1994;7(1):10-4.
1994: STEFANO VELLA; M Giuliano; L G Dally; M G Agresti; C Tomino; Marco Floridia; Antonio Chiesi; Vincenzo Fragola; Mauro Moroni; M Piazza
Long-term follow-up of zidovudine therapy in asymptomatic HIV infection: results of a multicenter cohort study. The Italian Zidovudine Evaluation Group.
Journal of acquired immune deficiency syndromes 1994;7(1):31-8.
1992: E Sieh; M L Coluzzi; Maria Gabriella Cusella De Angelis; A Mezzogiorno; Marco Floridia; Rita Canipari; Giulio Cossu; STEFANO VELLA
The effects of AZT and DDI on pre- and postimplantation mammalian embryos: an in vivo and in vitro study.
AIDS research and human retroviruses 1992;8(5):639-49.
1992: STEFANO VELLA; M Giuliano; Patrizio Pezzotti; M G Agresti; C Tomino; Marco Floridia; D Greco; Mauro Moroni; G Visco; Francesco Milazzo
Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group.
JAMA : the journal of the American Medical Association 1992;267(9):1232-6.
1990: STEFANO VELLA; Loredana Sarmati; G Milanese; Giovanni Rocchi
[Infectious diseases].
Medicina (Florence, Italy) 1990;10(4):442-5.
1990: Antonio Chiesi; M G Agresti; L G Dally; Mauro Zaccarelli; C Tomino; Marco Floridia; STEFANO VELLA
[Decrease in notifications of AIDS dementia complex in 1989-1990 in Italy: possible role of the early treatment with zidovudine].
Medicina (Florence, Italy) 1990;10(4):415-6.
1990: Loredana Sarmati; STEFANO VELLA; Giovanni Rocchi
[Controversies concerning the use of zidovudine in the treatment of asymptomatic HIV+ subjects with a low number of CD4+ lymphocytes].
Medicina (Florence, Italy) 1990;10(2):195-7.
1989: Giulio Cossu; Maria Gabriella Cusella De Angelis; M I Senni; Luciana De Angelis; Elisabetta Vivarelli; STEFANO VELLA; M Bouchè; Carla Boitani; Mario Molinaro
Adrenocorticotropin is a specific mitogen for mammalian myogenic cells.
Developmental biology 1989;131(2):331-6.
1988: Gianfranco Donelli; Franco Maria Ruggeri; Antonella Tinari; M L Marziano; D Menichella; D Caione; C Concato; Giovanni Rocchi; STEFANO VELLA
A three-year diagnostic and epidemiological study on viral infantile diarrhoea in Rome.
Epidemiology and infection 1988;100(2):311-20.
1982: E C DeFreitas; STEFANO VELLA; A Linnenbach; C Zmijewski; H Koprowski; C M Croce
Antigen-specific human T-cell hybridomas with helper activity.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(21):6646-50.
1982: E C DeFreitas; STEFANO VELLA; A Linnenbach; C M Croce; H Koprowski
Human T cell hybridomas with tetanus-toxoid-specific helper activity.
Current topics in microbiology and immunology 1982;100():191-201.
1981: G U Rochi; STEFANO VELLA; Silvia Resta-Lenert; S Cochi; Gianfranco Donelli; F Tangucci; D Menichella; A Varveri; R Inglese
Outbreak of rotavirus gastroenteritis among premature infants.
British medical journal (Clinical research ed.) 1981;283(6296):886.
1980: S Crifö; STEFANO VELLA; F Filiaci; Silvia Resta-Lenert; Giovanni Rocchi
Secretory immune response after nasal vaccination with live attenuated influenza viruses.
Rhinology 1980;18(2):87-92.
1980: STEFANO VELLA; Giovanni Rocchi; Silvia Resta-Lenert; M Marcelli; A De Felici
Antibody reactive in antibody-dependent cell-mediated cytotoxicity following influenza virus vaccination.
Journal of medical virology 1980;6(3):203-11.
1979: G Rocchi; G Ragona; C Piga; A Pelosio; A Volpi; STEFANO VELLA; N Legniti; A de Felici
Influenza vaccination with live-attenuated and inactivated virus-vaccines during an outbreak of disease.
The Journal of hygiene 1979;83(3):383-90.